Onconova Therapeutics
$15.06 M
Share price
Change (1 day)
Change (1 year)

Revenue for Onconova Therapeutics (ONTX)

Revenue in 2022 (TTM): $0.22 M

According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM) is $0.22 M. In 2021 the company made a revenue of $0.22 M a decrease over the years 2020 revenue that were of $0.23 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Onconova Therapeutics from 2012 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$0.22 M
2021$0.22 M-2.16%
2020$0.23 M-89.42%
2019$2.18 M77.77%
2018$1.22 M56.04%
2017$0.78 M-85.81%
2016$5.54 M-51.59%
2015$11.45 M1332%
2014$0.8 M-83.17%
2013$4.75 M-89.71%
2012$46.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$15.11 B 6,687,068.14%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$32.86 M 14,442.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.63 M 179.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.45 B 642,847.35%๐Ÿ‡บ๐Ÿ‡ธ USA